SCHEMBL13065754

SCHEMBL13065754

CC(C)(C)[Si](C)(C)c1cccc(NC(=O)c2cc(N)cc(C(=O)Nc3cccc([Si](C)(C)C(C)(C)C)c3)c2)c1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PTGS1 P23219 3/20 0.45
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ RXFP1 Q9HBX9 2/20 0.44
▸ KCNK9 Q9NPC2 3/20 0.44
▸ TOP1 P11387 2/20 0.42
▸ TOP2A P11388 1/20 0.42
▸ TOP2B Q02880 1/20 0.42
▸ THRB P10828 1/20 0.42
▸ HDAC3 O15379 1/20 0.42
▸ HDAC8 Q9BY41 1/20 0.42
▸ HDAC6 Q9UBN7 1/20 0.42
▸ KCNK3 O14649 3/20 0.42
▸ MAPT P10636 1/20 0.42
▸ CA1 P00915 1/20 0.41
▸ CA2 P00918 1/20 0.41
▸ KCNH2 Q12809 1/20 0.41
▸ SIRT2 Q8IXJ6 1/20 0.41
▸ SIRT1 Q96EB6 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13066001 0.83 TOP1 (0.46) PTGS1MEN1KMT2ARXFP1KCNK9
SCHEMBL13066016 0.77 MAPT (0.55) PTGS1MEN1KMT2ARXFP1KCNK9
SCHEMBL13023160 0.77 IKBKB (0.44) PTGS1MEN1KMT2ARXFP1
SCHEMBL13065680 0.75 IKBKB (0.42) MEN1KMT2ARXFP1
SCHEMBL13066011 0.74 HDAC3 (0.55) PTGS1MEN1KMT2AKCNK9TOP1
SCHEMBL11508480 0.74 PTGS1 (0.65) PTGS1MEN1KMT2AKCNK9TOP1
SCHEMBL17993344 0.73 HDAC2 (0.61) MEN1KMT2AKCNK9HDAC3HDAC8
SCHEMBL26737633 0.73 DDX3X (0.69) PTGS1MEN1KMT2ARXFP1KCNK9
SCHEMBL13065757 0.73 MEN1 (0.51) PTGS1MEN1KMT2ATOP1TOP2A
SCHEMBL13023070 0.72 LMNA (0.47) PTGS1MEN1KMT2ARXFP1KCNK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286353-A1 ACETYLENE COMPOUND, SALT THEREOF, CONDENSATE THEREOF, AND COMPOSITION THEREOF FUJIFILM CORPORATION (JP) 2010-11-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286353-A1 ACETYLENE COMPOUND, SALT THEREOF, CONDENSATE THEREOF, AND COMPOSITION THEREOF KAT8, HDAC10, SSRP1 PTGS1 1565/4885MEN1 379/4885KMT2A 583/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback